{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T18:18:50Z","timestamp":1776277130101,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,7,24]],"date-time":"2014-07-24T00:00:00Z","timestamp":1406160000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s00784-014-1280-8","type":"journal-article","created":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T04:53:43Z","timestamp":1406091223000},"page":"601-611","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Zoledronic acid at subtoxic dose extends osteoblastic stage span of primary human osteoblasts"],"prefix":"10.1007","volume":"19","author":[{"given":"Susi","family":"Zara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"De Colli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviana","family":"di Giacomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo Luca","family":"Zizzari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Di Nisio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Di Tore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Salini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marialucia","family":"Gallorini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Tet\u00e8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia","family":"Cataldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,24]]},"reference":[{"key":"1280_CR1","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","volume":"333","author":"UA Liberman","year":"1995","unstructured":"Liberman UA, Weiss SR, Br\u00f6ll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW Jr, Dequeker J, Favus M (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 333:1437\u20131443","journal-title":"N Engl J Med"},{"key":"1280_CR2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/ctrv.2000.0210","volume":"27","author":"RE Coleman","year":"2001","unstructured":"Coleman RE (2001) Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 27:65\u201376","journal-title":"Cancer Treat Rev"},{"key":"1280_CR3","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1172\/JCI0215952","volume":"110","author":"F Rauch","year":"2002","unstructured":"Rauch F, Travers R, Plotkin H, Glorieux FH (2002) The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfect. J Clin Invest 110:1293\u20131299","journal-title":"J Clin Invest"},{"key":"1280_CR4","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/jnci\/djh141","volume":"96","author":"F Saad","year":"2004","unstructured":"Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, Lacombe L, Chin JL, Vinholes JJ, Goas JA, Zheng M (2004) Zoledronic Acid Prostate Cancer Study Group. Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. J Natl Cancer Inst 96:879\u2013882","journal-title":"J Natl Cancer Inst"},{"key":"1280_CR5","first-page":"1351","volume":"15","author":"D Santini","year":"2006","unstructured":"Santini D, Vincenzi B, Hannon RA, Brown JE, Dicuonzo G, Angeletti S, La Cesa A, Coleman RE, Tonini G, Budillon A, Caraglia M, Holen I (2006) Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours. Oncol Rep 15:1351\u20131357","journal-title":"Oncol Rep"},{"key":"1280_CR6","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/00001622-200211000-00004","volume":"14","author":"LR Green","year":"2002","unstructured":"Green LR (2002) Bisphosphonates in cancer therapy. Curr Opin Oncol 14:609\u2013615","journal-title":"Curr Opin Oncol"},{"key":"1280_CR7","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.2174\/1381612033453640","volume":"9","author":"MJ Rogers","year":"2003","unstructured":"Rogers MJ (2003) New insights into the molecular mechanisms of action of bisphosphonates. Curr Pharm Des 9:2643\u20132658","journal-title":"Curr Pharm Des"},{"issue":"1","key":"1280_CR8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/bcr414","volume":"4","author":"H Fleisch","year":"2002","unstructured":"Fleisch H (2002) Development of bisphosphonates. Breast Cancer Res 4(1):30\u201334","journal-title":"Breast Cancer Res"},{"key":"1280_CR9","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1359\/jbmr.2000.15.4.613","volume":"15","author":"T Mashiba","year":"2000","unstructured":"Mashiba T, Hirano T, Turner CH, Forwood MH, Johnston CC, Burr DB (2000) Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res 15:613\u2013620","journal-title":"J Bone Miner Res"},{"key":"1280_CR10","first-page":"6001","volume":"60","author":"GG Reinholz","year":"2000","unstructured":"Reinholz GG, Getz B, Pederson L, Sanders ES, Subramaniam M, Ingle JN, Spelsberg TC (2000) Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Cancer Res 60:6001\u20136007","journal-title":"Cancer Res"},{"key":"1280_CR11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.oraloncology.2005.08.001","volume":"42","author":"JV Bagan","year":"2006","unstructured":"Bagan JV, Jimenez Y, Murillo J, Hernandez S, Poveda R, Sanchis JM, Diaz JM, Scully C (2006) Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases. Oral Oncol 42:327\u2013329","journal-title":"Oral Oncol"},{"key":"1280_CR12","first-page":"455","volume":"24","author":"EC Rizos","year":"2006","unstructured":"Rizos EC, Milionis HJ, Elisaf MS (2006) Fever with rash following zoledronic acid administration. Clin Exp Rheumatol 24:455","journal-title":"Clin Exp Rheumatol"},{"key":"1280_CR13","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bone.2007.04.196","volume":"41","author":"IR Reid","year":"2007","unstructured":"Reid IR, Bolland MJ, Grey AB (2007) Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone 41:318\u2013320","journal-title":"Bone"},{"issue":"6","key":"1280_CR14","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1210\/endo.137.6.8641182","volume":"137","author":"C Vitt\u00e9","year":"1996","unstructured":"Vitt\u00e9 C, Fleisch H, Guenther HL (1996) Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption. Endocrinology 137(6):2324\u20132333","journal-title":"Endocrinology"},{"key":"1280_CR15","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1006\/bbrc.2002.6510","volume":"291","author":"V Viereck","year":"2002","unstructured":"Viereck V, Emons G, Lauck V, Blaschke S, Gr\u00fcndker C, Hofbauer LC (2002) Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts. Biochem Biophys Res Commun 291:680\u2013686","journal-title":"Biochem Biophys Res Commun"},{"key":"1280_CR16","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1038\/emm.2013.16","volume":"45","author":"YJ Lee","year":"2013","unstructured":"Lee YJ, Jeong JK, Seol JW, Xue M, Jackson C, Park SY (2013) Activated protein C differentially regulates both viability and differentiation of osteoblasts mediated by bisphosphonates. Exp Mol Med 45:e9","journal-title":"Exp Mol Med"},{"key":"1280_CR17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1254\/jjp.66.25","volume":"66","author":"M Tsuchimoto","year":"1994","unstructured":"Tsuchimoto M, Azuma Y, Higuchi SI, Hirata N, Kiyoki M, Yamamoto I (1994) Alendronate modulates osteogenesis of human osteoblastic cells in vitro. Jpn J Pharmacol 66:25\u201333","journal-title":"Jpn J Pharmacol"},{"key":"1280_CR18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1067\/mlc.2000.109757","volume":"136","author":"Y Abe","year":"2000","unstructured":"Abe Y, Kawakami A, Nakashima T, Ejima E, Fujiyama K, Kiriyama T, Ide A, Sera N, Usa T, Tominaga T, Ashizawa K, Yokoyama N, Eguchi K (2000) Etidronate inhibits human osteoblast apoptosis by inhibition of pro-apoptotic factor(s) produced by activated T cells. J Lab Clin Med 136:344\u2013354","journal-title":"J Lab Clin Med"},{"key":"1280_CR19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bone.2003.08.013","volume":"34","author":"B Pan","year":"2004","unstructured":"Pan B, To LB, Farrugia AN, Findlay DM, Green J, Gronthos S, Evdokiou A, Lynch K, Atkins GJ, Zannettino AC (2004) The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro. Bone 34:112\u2013123","journal-title":"Bone"},{"key":"1280_CR20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/147323000903700216","volume":"37","author":"Y Xiong","year":"2009","unstructured":"Xiong Y, Yang HJ, Feng J, Shi ZL, Wu LD (2009) Effects of alendronate on the proliferation and osteogenic differentiation of MG-63 cells. J Int Med Res 37:407\u2013416","journal-title":"J Int Med Res"},{"key":"1280_CR21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00784-009-0312-2","volume":"14","author":"MJ Simon","year":"2010","unstructured":"Simon MJ, Niehoff P, Kimmig B, Wiltfang J, A\u00e7il Y (2010) Expression profile and synthesis of different collagen types I, II, III, and V of human gingival fibroblasts, osteoblasts, and SaOS-2 cells after bisphosphonate treatment. Clin Oral Investig 14:51\u201358","journal-title":"Clin Oral Investig"},{"key":"1280_CR22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.tripleo.2008.03.036","volume":"106","author":"A Naidu","year":"2008","unstructured":"Naidu A, Dechow PC, Spears R, Wright JM, Kessler HP, Opperman LA (2008) The effects of bisphosphonates on osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106:5\u201313","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"1280_CR23","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1007\/s11999-008-0409-y","volume":"467","author":"HK Kim","year":"2009","unstructured":"Kim HK, Kim JH, Abbas AA, Yoon TR (2009) Alendronate enhances osteogenic differentiation of bone marrow stromal cells: a preliminary study. Clin Orthop Relat Res 467:3121\u20133128","journal-title":"Clin Orthop Relat Res"},{"key":"1280_CR24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/jcb.21983","volume":"106","author":"IR Orriss","year":"2009","unstructured":"Orriss IR, Key ML, Colston KW, Arnett TR (2009) Inhibition of osteoblast function in vitro by aminobisphosphonates. J Cell Biochem 106:109\u2013118","journal-title":"J Cell Biochem"},{"key":"1280_CR25","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1158\/1078-0432.CCR-09-0426","volume":"15","author":"S Pozzi","year":"2009","unstructured":"Pozzi S, Vallet S, Mukherjee S, Cirstea D, Vaghela N, Santo L, Rosen E, Ikeda H, Okawa Y, Kiziltepe T, Schoonmaker J, Xie W, Hideshima T, Weller E, Bouxsein ML, Munshi NC, Anderson KC, Raje N (2009) High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties. Clin Cancer Res 15:5829\u20135839","journal-title":"Clin Cancer Res"},{"key":"1280_CR26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bone.2010.08.008","volume":"49","author":"T Bellido","year":"2011","unstructured":"Bellido T, Plotkin LI (2011) Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability. Bone 49:50\u201355","journal-title":"Bone"},{"key":"1280_CR27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0952-3278(97)90508-1","volume":"56","author":"K Igarashi","year":"1997","unstructured":"Igarashi K, Hirafuji M, Adachi H, Shinoda H, Mitani H (1997) Effects of bisphosphonates on alkaline phosphatase activity, mineralization, and prostaglandin E2 synthesis in the clonal osteoblast-like cell line MC3T3-E1. Prostaglandins Leukot Essent Fat Acids 56:121\u2013125","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"key":"1280_CR28","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/endo.138.9.5364","volume":"138","author":"T Bellido","year":"1997","unstructured":"Bellido T, Borba VZ, Roberson P, Manolagas SC (1997) Activation of the Janus kinase\/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation. Endocrinology 138:3666\u20133676","journal-title":"Endocrinology"},{"key":"1280_CR29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402\u2013408","journal-title":"Methods"},{"key":"1280_CR30","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1016\/S0142-9612(03)00317-X","volume":"24","author":"C Schmidt","year":"2003","unstructured":"Schmidt C, Steinbach G, Decking R, Claes LE, Ignatius AA (2003) IL-6 and PGE2 release by human osteoblasts on implant materials. Biomaterials 24:4191\u20134196","journal-title":"Biomaterials"},{"key":"1280_CR31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S8756-3282(95)00150-6","volume":"17","author":"H Murakami","year":"1995","unstructured":"Murakami H, Takahashi N, Sasaki T, Udagawa N, Tanaka S, Nakamura I, Zhang D, Barbier A, Suda T (1995) A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders. Bone 17:137\u2013144","journal-title":"Bone"},{"key":"1280_CR32","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00003086-199408000-00032","volume":"305","author":"RK Sinha","year":"1994","unstructured":"Sinha RK, Morris F, Shah SA, Tuan RS (1994) Surface composition of orthopaedic implant metals regulates cell attachment, spreading, and cytoskeletal organization of primary human osteoblasts in vitro. Clin Orthop Relat Res 305:258\u2013272","journal-title":"Clin Orthop Relat Res"},{"key":"1280_CR33","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1016\/j.biomaterials.2003.11.024","volume":"25","author":"GI Im","year":"2004","unstructured":"Im GI, Qureshi SA, Kenney J, Rubash HE, Shanbhag AS (2004) Osteoblast proliferation and maturation by bisphosphonates. Biomaterials 25:4105\u20134115","journal-title":"Biomaterials"},{"key":"1280_CR34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/jbm.a.30950","volume":"80","author":"S Greiner","year":"2007","unstructured":"Greiner S, Kadow-Romacker A, L\u00fcbberstedt M, Schmidmaier G, Wildemann B (2007) The effect of zoledronic acid incorporated in a poly(D, L-lactide) implant coating on osteoblasts in vitro. J Biomed Mater Res A 80:769\u2013775","journal-title":"J Biomed Mater Res A"},{"key":"1280_CR35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1440-1681.2004.03975.x","volume":"31","author":"SL Chan","year":"2004","unstructured":"Chan SL, Yu VC (2004) Proteins of the bcl-2 family in apoptosis signalling: from mechanistic insights to therapeutic opportunities. Clin Exp Pharmacol Physiol 31:119\u2013128","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1280_CR36","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.bbabio.2006.05.032","volume":"1757","author":"E Er","year":"2006","unstructured":"Er E, Oliver L, Cartron PF, Juin P, Manon S, Vallette FM (2006) Mitochondria as the target of the pro-apoptotic protein Bax. Biochim Biophys Acta 1757:1301\u20131311","journal-title":"Biochim Biophys Acta"},{"key":"1280_CR37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00223-006-0168-2","volume":"80","author":"W Zhang","year":"2007","unstructured":"Zhang W, Pantschenko AG, McCarthy MB, Gronowicz G (2007) Bone-targeted verexpression of Bcl-2 increases osteoblast adhesion and differentiation and inhibits mineralization in vitro. Calcif Tissue Int 80:111\u2013122","journal-title":"Calcif Tissue Int"},{"key":"1280_CR38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/(SICI)1097-4644(19980101)68:1<31::AID-JCB4>3.0.CO;2-X","volume":"68","author":"MP Lynch","year":"1998","unstructured":"Lynch MP, Capparelli C, Stein JL, Stein GS, Lian JB (1998) Apoptosis during bone-like tissue development in vitro. J Cell Biochem 68:31\u201349","journal-title":"J Cell Biochem"},{"key":"1280_CR39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/jbm.b.30287","volume":"75","author":"M Marchisio","year":"2005","unstructured":"Marchisio M, Di Carmine M, Pagone R, Piattelli A, Miscia S (2005) Implant surface roughness influences osteoclast proliferation and differentiation. J Biomed Mater Res B Appl Biomater 75:251\u2013256","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"1280_CR40","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/(SICI)1097-0029(19960201)33:2<128::AID-JEMT4>3.0.CO;2-P","volume":"33","author":"JE Aubin","year":"1996","unstructured":"Aubin JE, Turksen K (1996) Monoclonal antibodies as tools for studying the osteoblast lineage. Microsc Res Tech 33:128\u2013140","journal-title":"Microsc Res Tech"},{"key":"1280_CR41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1746-160X-6-12","volume":"6","author":"FP Koch","year":"2010","unstructured":"Koch FP, Yekta SS, Merkel C, Ziebart T, Smeets R (2010) The impact of bisphosphonates on the osteoblast proliferation and collagen gene expression in vitro. Head Face Med 6:12","journal-title":"Head Face Med"},{"key":"1280_CR42","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/jcp.24278","volume":"228","author":"A Neve","year":"2013","unstructured":"Neve A, Corrado A, Cantatore FP (2013) Osteocalcin: skeletal and extra-skeletal effects. J Cell Physiol 228:1149\u20131153","journal-title":"J Cell Physiol"},{"key":"1280_CR43","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1128\/MCB.02120-05","volume":"26","author":"K Zhang","year":"2006","unstructured":"Zhang K, Barragan-Adjemian C, Ye L, Kotha S, Dallas M, Lu Y, Zhao S, Harris M, Harris SE, Feng JQ, Bonewald LF (2006) E11\/gp38 selective expression in osteocytes: regulation by mechanical strain and role in dendrite elongation. Mol Cell Biol 26:4539\u20134552","journal-title":"Mol Cell Biol"},{"key":"1280_CR44","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.bcp.2006.09.031","volume":"73","author":"MF Moreau","year":"2007","unstructured":"Moreau MF, Guillet C, Massin P, Chevalier S, Gascan H, Basl\u00e9 MF, Chappard D (2007) Comparative effects of five bisphosphonates on apoptosis of macrophage cells in vitro. Biochem Pharmacol 73:718\u2013723","journal-title":"Biochem Pharmacol"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-014-1280-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00784-014-1280-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-014-1280-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T03:04:26Z","timestamp":1565665466000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00784-014-1280-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,24]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["1280"],"URL":"https:\/\/doi.org\/10.1007\/s00784-014-1280-8","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"value":"1432-6981","type":"print"},{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,24]]}}}